REGENSKIN
LIVE

Serial Number

98391336

Owner

REGENLAB USA LLC

Attorney

Lindsay H. Kaplan

Filing Date

Feb 5, 2024

Add to watchlist:

No watchlists yet
View on USPTO

REGENSKIN Trademark

Serial Number: 98391336

REGENSKIN is a trademark filed by REGENLAB USA LLC on February 5, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

REGENLAB USA LLC

95 Greene Street
Jersey City, NJ 07302

Entity Type: 16

Trademark Details

Filing Date

February 5, 2024

Registration Date

Not Registered

Published for Opposition

January 14, 2025

Goods & Services

research services, namely, scientific research studies, in the field of tissue and cellular regeneration and rejuvenation, regenerative medicine, isolation and application of a patient's own platelets and cells; Electronic storage services in the nature of database management, namely, electronic storage of business records of others

Biological preparations for the treatment of wounds, damaged tissue, scars, and skin wrinkles, namely, platelet concentrate, platelet rich plasma, platelet poor plasma, fibrin gel, platelet rich fibrin, cell extracts, cell concentrates, stem cells, hyaluronic acid, silk, chitosan or any combinations thereof; such goods not including implantable medical devices for use in the regeneration of natural tissue

medical services, namely, treatments using platelet rich plasma, platelet poor plasma, platelet rich fibrin, blood platelet concentrate, platelet fibrin gel, white blood cells, buffy coat, stem cells, and other blood related extracts or any combination of blood contents in the field of tissue and cellular enhancement, repair, reconstruction, regeneration and rejuvenation, regenerative medicine; medical services, namely, treatments using platelet rich plasma, platelet poor plasma, platelet rich fibrin, blood platelet concentrate, platelet fibrin gel, white blood cells, buffy coat, stem cells, and other blood related extracts or any combination of blood contents in the field of blood or bone marrow related components including platelets, plasma concentrates, thrombin serum and stem cells, to mesotherapy, to hyaluronic acid, chitosan or silk, to the isolation, application, micro-needling and/or injection of a patient's own platelets, thrombin serum and/or cells alone or in combination with any other substance including cell extract or cell extracts, stem cells, hyaluronic acid, silk, or chitosan; Providing medical, veterinary and surgical information in the field of tissue and cellular regeneration and rejuvenation, regenerative medicine, isolation and application of a patient's own platelets and cells via the Internet; providing healthcare consultancy and advice for business executives, health care workers, health care specialists, medical doctors and patients in the fields of cellular and tissue regeneration, regenerative medicine, rejuvenation, as well as isolating, treating and injecting blood platelets or cells into patients

Medical kits comprised primarily of blood collecting tubes, syringes for medical purposes, needles for medical use, connectors for attaching blood collection tubes, centrifuges, syringes, and injection apparatus, nozzles for dispensing biological preparations, stoppers for the sealing of tubes and vials, adapters for connecting syringes to blood collection tubes, transfer devices for the transfer of biological preparations, also including thixotropic gels, anticoagulants, coagulation activating preparations, and hyaluronic acid for pharmaceutical purposes, the aforementioned medical kits intended for the preparation of platelet concentrate, platelet rich plasma, platelet poor plasma, fibrin gel, platelet rich fibrin, cell extracts, cell concentrates, stem cells, hyaluronic acid, silk, chitosan or any combinations thereof; medical kits intended for tissue and cellular regeneration, rejuvenation, healing and repair comprised of receptacles, namely blood collecting and sampling tubes, vials, jars, bags, pouches, cartridges, bottles, cylinders or pods for blood testing apparatus, medical syringes and needles, the aforementioned for regenerative medicine, isolation and application of platelets and cells, for example from blood, fat, bone marrow, stem cells and other tissue; and medical kits comprising blood collecting and sampling tubes for blood testing apparatus, and medical syringes and needles for regenerative medicine, the aforementioned kits for the preparation of a platelet concentrate, the isolation and application of platelets and cells, for example from blood, fat, bone marrow, stem cells and other tissue; such goods not including implantable medical devices for use in the regeneration of natural tissue.

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2026 EXRA
SOU EXTENSION 2 GRANTED
Mar 2, 2026 EX2G
SOU EXTENSION 2 FILED
Mar 2, 2026 EXT2
SOU TEAS EXTENSION RECEIVED
Mar 2, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 11, 2025 EXRA
SOU EXTENSION 1 GRANTED
Sep 10, 2025 EX1G
SOU EXTENSION 1 FILED
Sep 10, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Sep 10, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 11, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 14, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jan 14, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 8, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 23, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 23, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 23, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 23, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 9, 2024 GNRN
NON-FINAL ACTION E-MAILED
Sep 9, 2024 GNRT
NON-FINAL ACTION WRITTEN
Sep 9, 2024 CNRT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 5, 2024 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 5, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 5, 2024 COAR
ASSIGNED TO EXAMINER
Aug 28, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 2, 2024 NWOS
NEW APPLICATION ENTERED
Feb 5, 2024 NWAP